The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

According to The Business Research Company’s Large Volume Parenteral (LVP) Global Market Report 2024, the large volume parenteral (LVP) market is expected to show promising growth in the forecast period.

Market Overview

The large volume parenteral (LVP) market has experienced robust growth in recent years, with promising projections for the future. From a valuation of $11.42 billion in 2023, it is expected to reach $12.44 billion in 2024, showcasing a Compound Annual Growth Rate (CAGR) of 9.0%.

Factors Driving Growth

• Increasing prevalence of chronic diseases
• Growth in the aging population
• Rising demand for sterile pharmaceuticals
• Expansion of healthcare infrastructure
• Development of regulatory frameworks for pharmaceuticals

Projected Growth

Strong growth is anticipated in the coming years, with the market expected to expand to $17.35 billion by 2028, driven by factors such as growing demand for biologics and biosimilars, rising healthcare expenditure, and the globalization of pharmaceutical supply chains.

View More On The Large Volume Parenteral (LVP) Market Report 2024 – https://www.thebusinessresearchcompany.com/report/large-volume-parenteral-lvp-global-market-report

Key Trends in the Forecast Period

• Technological advancements in manufacturing processes
• Integration of advanced technologies in pharmaceutical production
• Implementation of single-use technologies
• Development of high-concentration formulations
• Rise in 3D printing applications for pharmaceuticals

Large-Volume Parenteral Market Thrives on the Surge in Chronic Diseases

The growing prevalence of chronic diseases serves as a significant driver for market expansion. With chronic illnesses on the rise globally, there’s an increasing demand for efficient parenteral administration of pharmaceuticals to manage these conditions effectively.

Key Statistics:

• Projected 99.5% surge in individuals aged 50 years and older with at least one chronic illness in the US by 2050

Strategic Acquisitions Shape Market Growth

Product innovation emerges as a key trend, with major players focusing on creating innovative solutions to meet evolving market needs. Strategic acquisitions, such as Fresenius Kabi’s acquisition of Ivenix Inc., bolster market presence and enhance product portfolios.

Recent Developments:

• Launch of sterile and ready-to-use 100-ml type I molded glass vials by SGD Pharma SA
• Fresenius Kabi’s acquisition of Ivenix Inc., strengthening its position in the US market and expanding access to infusion systems

Market Segmentation

The large volume parenteral (LVP) market is segmented based on type, volume, application, and end-users, providing insights into diverse product offerings and consumer preferences.

Segmentation:

1. By Type:
   • Soft Bag LVP
   • Plastic Bag LVP
   • Glass Bottle LVP
2. By Volume:
   • 100 ML – 250 ML
   • 250 ML – 500 ML
   • 500 ML – 1000 ML
   • 1000 ML – 2000 ML
   • 2000 And More
3. By Application:
   • Basic Infusion
   • Therapeutics Infusion
   • Nutritious Infusion
4. By End-User:
   • Hospital
   • Medical Centers
   • Other End Users

Regional Outlook

While North America leads the large volume parenteral (LVP) market, Asia-Pacific emerges as the fastest-growing region, driven by expanding healthcare infrastructures and increasing focus on advanced pharmaceutical solutions.

In conclusion, the large volume parenteral (LVP) market demonstrates promising growth prospects, fueled by factors such as the rising prevalence of chronic diseases and technological advancements in pharmaceutical manufacturing. With a focus on innovation and strategic acquisitions, market players aim to address evolving healthcare needs and enhance patient outcomes worldwide.

Request A Sample Of The Global Large Volume Parenteral (LVP) Market Report 2024:
https://www.thebusinessresearchcompany.com/sample_request?id=12195&type=smp